Fu W - Search Results

1

Dysregulated circular RNAs are closely linked to multiple myeloma prognosis, with circ_0026652 predicting bortezomib‑based treatment response and survival via the microRNA‑608‑mediated Wnt/β‑catenin pathway.

Li L, Liu J, Du J, Jiang H, He H, Lu J, Qiang W, Hou N, Guo P, Zhuang Y, Fu W. Li L, et al. Among authors: fu w. Oncol Rep. 2022 Nov;48(5):195. doi: 10.3892/or.2022.8410. Epub 2022 Sep 21. Oncol Rep. 2022. PMID: 36129153 Free PMC article.

2

[Establishment of a human CD30+ anaplastic large cell lymphoma cell line and its biological characteristics].

Jiang H, Hou J, Fu WJ, Ding SQ, Zhang B. Jiang H, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2003 Oct;11(5):490-4. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2003. PMID: 14575543 Chinese.

3

Prognostic factors for the efficacy of thalidomide in the treatment of multiple myeloma: a clinical study of 110 patients in China.

Li Y, Hou J, Wang D, Fu W, Yuan Z, Chen Y, Tao Z. Li Y, et al. Among authors: fu w. Leuk Lymphoma. 2006 Dec;47(12):2593-600. doi: 10.1080/10428190600955753. Leuk Lymphoma. 2006. PMID: 17169804

4

Polymorphisms of CYP2C19 gene are associated with the efficacy of thalidomide based regimens in multiple myeloma.

Li Y, Hou J, Jiang H, Wang D, Fu W, Yuan Z, Chen Y, Zhou L. Li Y, et al. Among authors: fu w. Haematologica. 2007 Sep;92(9):1246-9. doi: 10.3324/haematol.11319. Epub 2007 Aug 1. Haematologica. 2007. PMID: 17666363 Free article.

5

[Clinical features of multiple myeloma patients with extramedullary disease: a report of 40 cases from a single center].

Chen HF, Fu WJ, Wang DX, Yuan ZG, Chen YB, Hou J. Chen HF, et al. Zhonghua Xue Ye Xue Za Zhi. 2007 Oct;28(10):655-8. Zhonghua Xue Ye Xue Za Zhi. 2007. PMID: 18399168 Chinese.

6

Arsenic trioxide and 2-methoxyestradiol reduce beta-catenin accumulation after proteasome inhibition and enhance the sensitivity of myeloma cells to Bortezomib.

Zhou L, Hou J, Fu W, Wang D, Yuan Z, Jiang H. Zhou L, et al. Among authors: fu w. Leuk Res. 2008 Nov;32(11):1674-83. doi: 10.1016/j.leukres.2008.03.039. Epub 2008 May 15. Leuk Res. 2008. PMID: 18485479

7

[The impact of autologous stem cell transplantation on the prognosis in multiple myeloma].

Li YH, Hou J, Wang DX, Fu WJ, Yuan ZG, Chen YB, Xi H. Li YH, et al. Zhonghua Xue Ye Xue Za Zhi. 2008 Apr;29(4):222-5. Zhonghua Xue Ye Xue Za Zhi. 2008. PMID: 18843973 Chinese.

8

[Study on the relationship of beta-catenin level and sensitivity to Bortezomib of myeloma cell lines].

Zhou LL, Fu WJ, Yuan ZG, Wang DX, Hou J. Zhou LL, et al. Zhonghua Xue Ye Xue Za Zhi. 2008 Apr;29(4):234-7. Zhonghua Xue Ye Xue Za Zhi. 2008. PMID: 18843976 Chinese.

9

[Effect of TNF-alpha gene polymorphism on outcome of thalidomide-based regimens for multiple myeloma].

DU J, Yuan ZG, Zhang CY, Fu WJ, Jiang H, Chen BA, Hou J. DU J, et al. Zhonghua Xue Ye Xue Za Zhi. 2009 Oct;30(10):649-53. Zhonghua Xue Ye Xue Za Zhi. 2009. PMID: 19954656 Chinese.

10

Role of the TNF-α promoter polymorphisms for development of multiple myeloma and clinical outcome in thalidomide plus dexamethasone.

Du J, Yuan Z, Zhang C, Fu W, Jiang H, Chen B, Hou J. Du J, et al. Among authors: fu w. Leuk Res. 2010 Nov;34(11):1453-8. doi: 10.1016/j.leukres.2010.01.011. Epub 2010 Jan 31. Leuk Res. 2010. PMID: 20122728

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,425 results

Search Page

Filters